LATEST ALERTS
CBD products are considered novel foods because there is no history of their consumption prior to May 1997. There is a stringent process for the authorisation of novel foods before they can be launched on the market, which includes an independent safety assessment to ensure the new products are safe for public consumption. All of our content that relates to CBD as a novel food can be accessed from this page.
France has created temporary guidelines allowing CBD companies to register their products as food supplements pending authorisation under the EU’s upcoming novel foods regulation
New resources and potential future regulatory changes are being applied to the UK novel food approval process in the hopes of improving processing time for applications, the UK Food Standards Agency (FSA) said
CBD isolate producers in the UK are waiting to see whether and how toxicological data released by the European Industrial Hemp Association (EIHA) will affect their novel food applications to the Food Standards Agency (FSA)
Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps
Companies are facing technical and marketing pros and cons as they increasingly turn to cold-press CBD extraction as a way around novel food market limitations in the UK and Ireland
The UK Food Standards Agency (FSA) has published its final public list of CBD products that can be marketed in England and Wales – and again it’s twice as long as it was
The European Food Safety Authority wants more safety data before it approves CBD products as novel food. This is what it wants to know, and why, along with a summary of the science on each point
In trying to be overly cautious on novel foods, has the European Food Safety Authority inadvertently added an extra risk to public health?
CBD companies say they do not know when or even how they will be able to provide the missing data that has caused the European Food Safety Authority (EFSA) to pause the clock on assessing novel food applications
The recent update to the UK Food Standards Agency (FSA)’s list of CBD products linked to validated novel food applications has created further issues and questions in the industry – such as, what will actually change?
The list of products linked to novel food applications in the UK has nearly doubled in length with the addition of 2,446 products by the Foods Standards Agency (FSA)
The European Commission has emphasised once again that EU member states must apply the ruling of the Courts of Justice of the European Union (CJEU) in the Kanavape decision to national law
The UK Food Standards Agency (FSA) is to update its list of products linked to validated CBD novel food applications to reflect those linked to a credible application and which were on the market before February 2020
A Polish appeals court has accepted arguments that hemp was consumed before 1997, making it non-novel and leading the court to overturn a decision by the country’s Chief Sanitary Inspectorate
Maximum THC levels for hempseed foods and oil across the EU are a major step forward in clarifying the regulation of hemp-derived products, according to the European Industrial Hemp Association (EIHA)
FOR IMMEDIATE RELEASE Many high street CBD products must be removed from sale, research shows The majority of CBD oral products now on the UK market will have to be removed from sale, significantly affecting many retailers and consumers, new analysis from CBD-Intel suggests. CBD-Intel compared the recent Food Standards Agency (FSA) list of oral CBD products which are allowed » Continue Reading.
The UK Food Standards Agency (FSA) has published a list of around 3,500 CBD food products whose applications for novel food status have been validated or still await validation
THC levels have been established for certain hemp foodstuffs, which may later govern the amount of THC allowed in ingestible cannabinoid products, experts working for the European Commission have confirmed
The European Food Safety Authority (EFSA) has validated the novel food applications of at least five CBD producers, marking what one company called an “important milestone” in the ongoing saga of EU CBD regulation
Don’t hold your breath, but rumours are swirling that the UK Food Standards Agency (FSA) will soon publish an updated, completed list of CBD novel food applications that have been fully validated
“Intoxicating” will be the word to watch for and THC will be the main driver for developments in 2022, CBD-Intel predicts
CBD-Intel was on point in its 2021 predictions. Much like the preceding year, we believed 2021 would largely be defined more by what did not happen than what did
Slovenia’s stance on CBD in the light of the Kanavape case isn’t clear; recreational cannabis rules not likely change; medicinal cannabis rules might change
A market that cannot innovate stagnates – and that is exactly what is happening with CBD in the UK because of delays in the novel food application process which mean companies cannot introduce any new products
A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA)
The European Commission (EC) has validated a novel food application submitted by the Italian company Farmabios for a synthetic CBD. This is the first step to gaining novel food authorisation from the European Food Safety Authority (EFSA). The company said it had also submitted a similar dossier to the UK Food Standards Agency (FSA) and expects to receive validation there » Continue Reading.
As CBD grows in popularity, its regulatory status remains poorly defined. In this report CBD-Intel reviews the regulatory framework of dietary supplements and where CBD fits, or would fit, within that framework
FOR IMMEDIATE RELEASE Adult toys could lead the UK’s CBD brands into mainstream retail More than 420 brands make up the fragmented online UK market, according to a new CBD-Intel research Adult products could show the way for the development of the CBD market in the UK, according to the latest findings from CBD-Intel. There remains significant room for CBD » Continue Reading.
Tim Phillips, CBD-Intel’s managing director, recently presented at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 28th April 2021. In addition to an overview of the impact of Covid-19 on the retail environment, he provided a comparative analysis of the current Novel Food legislation in the UK and the US, as well as discussion around how » Continue Reading.
The long-anticipated UK Food Standards Agency (FSA) initial list of products supported by a validated CBD novel food application has been released
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the list has been put forward, but the speculation is that it will now more than likely be at least May before it » Continue Reading.
Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that has been administratively checked (essentially scanned over to make sure all required bits are present) – under the assumption that the application » Continue Reading.
Companies now only to have submitted an application to the UK Food Standards Agency (FSA) in order for their edible CBD products to stay on the market after 1st April
There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient or white-label goods suppliers. But the FSA has not indicated that such information would be included in any list. And there is » Continue Reading.
As the UK’s deadline for novel food applications looms, many firms are upbeat about the prospects for CBD businesses in Northern Ireland, but almost all those CBD-Intel spoke to expressed frustration at a lack of clarity
FOR IMMEDIATE RELEASE US CBD market worth $3bn by 2023 New CBD-Intel modelling predicts sharp increase in US CBD market value over next two years The US CBD market will break the $3bn mark in 2023, new CBD-Intel market data modelling predicts, with massive growth stemming from anticipated regulatory changes. CBD-intel predicts US Food and Drug Administration (FDA) rules providing a » Continue Reading.
The UK Food Standards Agency (FSA) is moving forward at pace with at least one CBD novel food application having been validated
Investing in the medical cannabis and CBD space in the UK is only likely to continue as companies are now legally allowed to list on Europe’s biggest stock exchange, while demand by retail investors continues to spur interest
For many 2020 will always carry an asterisk. The CBD industry was – overall – more fortunate than many other sectors
Officials from the European Commission (EC) met with CBD-Intel to discuss the status of novel food applications in light of the ruling in the Kanavape case
The implications of the Kanavape ruling could be far-reaching. This report examines the decision by the Court of Justice of the European Union (CJEU) and some of its likely consequences
Concerns over traceability, limiting final use and demonstrating safety of final products could make it difficult to grant UK novel food approval to CBD ingredients producers and white label manufacturers
Companies do not feel much risk of a glut of CBD-containing food, drink and dietary supplement products or cannabinoid ingredients coming into the UK market if the EU classifies CBD as a narcotic
The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing CBD
The apparently unrelated fields of red yeast rice and stem cell research could provide clues as to how the US Food and Drug Administration (FDA) might deal with market regulation of CBD
There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
A decision by the German city of Düsseldorf to prohibit the sale of all foods containing CBD, including in natural extract form, faces a legal challenge from local hemp wholesaler Hempro International
CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.
FOR IMMEDIATE RELEASE CBD food products to remain illegal for three years New report from CBD-Intel explores issues surrounding CBD as a novel food Don’t expect to see legal CBD food and drink products before 2023 at the very earliest, a new report from CBD-Intel warns. The use of CBD as a food ingredient has been on hold since European » Continue Reading.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
